MedTech News
AI platform designs molecular missiles to attack cancer cells
Precision cancer treatment on a larger scale is moving closer now that researchers have developed an AI platform to tailor protein components and arm the patient’s immune cells to fight cancer.
Implant-Specific Salivary Test Introduced to Market
SimplyTest has launched SimplyTest Oral Health-IMPLANT, a new molecular assay designed to detect microbial species linked to peri-implant disease and implant failure. The test is the latest addition to the company’s growing SimplyTest Oral Health line, which also includes SimplyTest Oral Health-PERIO and others.
Neuros Medical Announces First Commercial Implant of the Altius® Direct Electrical Nerve Stimulation System, a Breakthrough Non-Opioid Treatment for Chronic Post-Amputation Pain
ALISO VIEJO, Calif., July 23, 2025 /PRNewswire/ — In a major milestone for chronic post-amputation pain treatment, the first commercial patient in the U.S. has been successfully implanted with the FDA-approved Altius® System – marking the beginning of the company’s mission to relieve pain and restore life for lower limb amputees.
Sutter Health Adopts Wearable Ultrasound to Optimize Sepsis Care
New AI-Enabled Technology Aims to Personalize Fluid Management and Improve Outcomes Across Hospital Network
Canada Grants Patent to bioAffinity Technologies for CyPath® Lung Diagnostic Test
New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets
Hesperos Unveils First Digital Twin of Human Disease with Organ-on-a-Chip Breakthrough
Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine.
How a Chatty Ancient Protein in Our Gut Could Be Giving Us a Sixth Sense
https://www.discovermagazine.com/health/how-a-chatty-ancient-protein-in-our-gut-could-be-giving-us-a-sixth-sense
FDA clears latest Philips image-guided navigation tech for prostate cancer
Philips (NYSE: PHG)+ announced today that it received FDA 510(k) clearance for the latest UroNav image-guided navigation system.